As many of you know, Jo Revill stepped down as the British Society for Immunology’s Chief Executive in May to become the CEO of the Royal College of Paediatrics and Child Health. We are pleased to announce that Jo will be succeeded by Dr Doug Brown, who will join the BSI as our new Chief Executive from Monday 3 September.
Doug is currently Chief Policy and Research Officer at the Alzheimer’s Society, the UK charity that funds research into dementia and supports people with this condition and their families. He is one of three Chief Officers working with the CEO to provide leadership, direction and financial management to the charity, which has a £100 million annual turnover with 2,500 staff and 10,000 volunteers. He has led a number of high profile initiatives across research and policy including the establishment of the new £300m UK Dementia Research Institute.
Doug comes from an immunology background, having completed a PhD at the University of Cambridge in HIV research, followed up by a postdoctoral position with Jean Langhorn at NIMR, Mill Hill (now the Francis Crick Institute) working on malaria and stem cells and publishing in top journals. He subsequently worked for the MS Society leading their biomedical research programme. He is currently a Trustee of the Association of Medical Research Charities (AMRC), the national umbrella organisation for medical research charities.
On his appointment, Doug says: “I cannot wait to join you all at the Society. It is such an exciting time for immunology research and more than ever before the role of the British Society for Immunology is crucial in supporting you all to maximise the impact of your research for human and animal health. I look forward to working with all of you to turn a challenging political, policy and research funding environment into significant opportunities that will benefit the UK and global immunology sector. And I am thrilled to be returning to immunology research!”
Professor Peter Openshaw, BSI President, warmly welcomes Doug to the Society. “We are absolutely delighted to have found a new Chief Executive with world-class organisational skills, an ambitious vision for the Society and a great background in immunological research. The skills and experience he will bring to the British Society for Immunology are first-rate.
“We look forward to introducing Doug more fully to our members, partners and stakeholders. Doug will be attending the European Congress of Immunology in Amsterdam in September and will be pleased to talk to as many members as possible during the Congress.”